Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ismail Celik

Showing results (161-170 of 188) with videos related to

Pageof 19
Sort By:
Chemotherapy|December 12, 2002
Modified ESHAP as salvage chemotherapy for recurrent or refractory non-Hodgkin's lymphoma: results of a single-center study of 32 patients. Modified etoposide, methylprednisolone, cytarabine and cisplatinMehmet Akif Oztürk, Ibrahim Barişta, M Kadri Altundağ, et al.
Journal of Molecular Liquids|July 26, 2021
Molecular docking, DFT analysis, and dynamics simulation of natural bioactive compounds targeting ACE2 and TMPRSS2 dual binding sites of spike protein of SARS CoV-2Rohitash Yadav, Shazia Hasan, Sumit Mahato, et al.
Journal of Medicinal Chemistry|April 30, 2026
Design and Synthesis of Bis-Triazole-Linked Benzenesulfonamides as Selective Carbonic Anhydrase IX/XII Inhibitors with Chemosensitizing ActivityEslam Roshdy, Ahmet Kilic, Muhamad Mustafa, et al.
Molecules (Basel, Switzerland)|September 28, 2021
In Silico Evaluation of Iranian Medicinal Plant Phytoconstituents as Inhibitors against Main Protease and the Receptor-Binding Domain of SARS-CoV-2Seyyed Sasan Mousavi, Akbar Karami, Tahereh Movahhed Haghighi, et al.
Future Medicinal Chemistry|July 4, 2025
Synthesis, antiproliferative evaluation and <i>in silico</i> studies of new quinazoline derivatives as VEGFR-2 inhibitorsAbdelsalam Mohamed Abdelsalam Ouf, Adel A Marzouk, Montaser Sh A Shaykoon, et al.
Journal of Medicinal Chemistry|January 26, 2026
First-in-Class Dual PDGFR/Carbonic Anhydrase IX/XII Inhibitors: 6,7-Dimethoxyquinoline-Sulfonamides as Promising Antileukemic AgentsEslam Roshdy, Eva Řezníčková, Mostafa M Elbadawi, et al.
Pharmaceuticals (Basel, Switzerland)|December 28, 2021
Appraisal of Bioactive Compounds of Betel Fruit as Antimalarial Agents by Targeting Plasmepsin 1 and 2: A Computational ApproachFatimawali, Trina Ekawati Tallei, Billy Johnson Kepel, et al.
Bioorganic Chemistry|April 29, 2026
Quinoxaline-based scaffolds as dual VEGFR-2/EGFR kinase inhibitors and apoptotic inducers: Design, synthesis, anticancer evaluation, and in silico studyAlaa Elwan, Samiha A El-Sebaey, Hanan A Al-Ghulikah, et al.
European Journal of Medicinal Chemistry|September 27, 2025
Design, synthesis, anticancer evaluation, biological screening, and computational study of novel 6,7-dimethoxyquinazoline derivatives as VEGFR-2 inhibitors and apoptotic inducersMostafa M A Aref, Abdallah E Abdallah, Mohammed A Dahab, et al.
Scientific Reports|November 6, 2023
Synthesis of novel pyrazolone candidates with studying some biological activities and in-silico studiesMagda H Abdellattif, Eman O Hamed, Nourhan Kh R Elhoseni, et al.
Pageof 19

Showing results (161-170 of 188) with videos related to

Sort By:
Pageof 19
Chemotherapy|December 12, 2002
Modified ESHAP as salvage chemotherapy for recurrent or refractory non-Hodgkin's lymphoma: results of a single-center study of 32 patients. Modified etoposide, methylprednisolone, cytarabine and cisplatinMehmet Akif Oztürk, Ibrahim Barişta, M Kadri Altundağ, et al.
Journal of Molecular Liquids|July 26, 2021
Molecular docking, DFT analysis, and dynamics simulation of natural bioactive compounds targeting ACE2 and TMPRSS2 dual binding sites of spike protein of SARS CoV-2Rohitash Yadav, Shazia Hasan, Sumit Mahato, et al.
Journal of Medicinal Chemistry|April 30, 2026
Design and Synthesis of Bis-Triazole-Linked Benzenesulfonamides as Selective Carbonic Anhydrase IX/XII Inhibitors with Chemosensitizing ActivityEslam Roshdy, Ahmet Kilic, Muhamad Mustafa, et al.
Molecules (Basel, Switzerland)|September 28, 2021
In Silico Evaluation of Iranian Medicinal Plant Phytoconstituents as Inhibitors against Main Protease and the Receptor-Binding Domain of SARS-CoV-2Seyyed Sasan Mousavi, Akbar Karami, Tahereh Movahhed Haghighi, et al.
Future Medicinal Chemistry|July 4, 2025
Synthesis, antiproliferative evaluation and <i>in silico</i> studies of new quinazoline derivatives as VEGFR-2 inhibitorsAbdelsalam Mohamed Abdelsalam Ouf, Adel A Marzouk, Montaser Sh A Shaykoon, et al.
Journal of Medicinal Chemistry|January 26, 2026
First-in-Class Dual PDGFR/Carbonic Anhydrase IX/XII Inhibitors: 6,7-Dimethoxyquinoline-Sulfonamides as Promising Antileukemic AgentsEslam Roshdy, Eva Řezníčková, Mostafa M Elbadawi, et al.
Pharmaceuticals (Basel, Switzerland)|December 28, 2021
Appraisal of Bioactive Compounds of Betel Fruit as Antimalarial Agents by Targeting Plasmepsin 1 and 2: A Computational ApproachFatimawali, Trina Ekawati Tallei, Billy Johnson Kepel, et al.
Bioorganic Chemistry|April 29, 2026
Quinoxaline-based scaffolds as dual VEGFR-2/EGFR kinase inhibitors and apoptotic inducers: Design, synthesis, anticancer evaluation, and in silico studyAlaa Elwan, Samiha A El-Sebaey, Hanan A Al-Ghulikah, et al.
European Journal of Medicinal Chemistry|September 27, 2025
Design, synthesis, anticancer evaluation, biological screening, and computational study of novel 6,7-dimethoxyquinazoline derivatives as VEGFR-2 inhibitors and apoptotic inducersMostafa M A Aref, Abdallah E Abdallah, Mohammed A Dahab, et al.
Scientific Reports|November 6, 2023
Synthesis of novel pyrazolone candidates with studying some biological activities and in-silico studiesMagda H Abdellattif, Eman O Hamed, Nourhan Kh R Elhoseni, et al.
Pageof 19